Scribe Therapeutics soars on New York Stock Exchange debut

Scribe Therapeutics achieves a successful IPO on the New York Stock Exchange.

Published 1sem2 sources✓ ConfirmedNotableupdated 6j

Lire en français

≈ 15sSpeed

The fact

The stock surges following an upsized fundraising.

This performance stands out amid a sluggish tech market.

2 sources — click a link to read an article on the topic:

Boursorama

Investing.com

Why it matters

Cette introduction en Bourse réussie marque un rare succès pour une entreprise biotech dans un contexte de marché tendu, attirant l'attention sur les opportunités sectorielles malgré les risques perçus.

Explore this topic

New York États-Unis Scribe Therapeutics NYSE #scribe therapeutics #introduction en bourse #nyse #biotech #levée de fonds #marchés financiers

What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.

Story timeline

coverage · 14d

Jul 13AB Science soars on the stock market following exceptional trading volumes

Jul 23Scribe Therapeutics soars on New York Stock Exchange debutthis article

FranceWorld map →

Follow topic →

Auto-synthesis from 2 media sources · identified on July 23, 2026

← Back to home

The fact

Why it matters

Story timeline

Read more

Wall Street closes higher following SK Hynix's record IPO

Csquare goes public on NYSE with $3.24 billion valuation

New York sues Kalshi over alleged illegal practices